Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free ELTP Stock Alerts $0.18 +0.01 (+5.73%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Elite Pharmaceuticals Short Interest DataCurrent Short Interest1,530,700 sharesPrevious Short Interest1,595,900 sharesChange Vs. Previous Month-4.09%Dollar Volume Sold Short$214,144.93Short Interest Ratio1.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,068,270,000 sharesPercentage of Shares Shorted0.14%Today's Trading Volume1,059,173 sharesAverage Trading Volume1,085,673 sharesToday's Volume Vs. Average98% Short Selling Elite Pharmaceuticals ? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,530,700 shares $214,144.93 -4.1%N/A1.3 $0.14 4/30/20241,595,900 shares $207,147.82 -0.3%N/A1.8 $0.13 4/15/20241,601,300 shares $216,175.50 +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240,106.74 -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234,173.30 +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258,066.90 +0.9%N/A0.4 $0.16 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,588,800 shares $293,769.12 +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18,008.40 +24.8%N/A0 $0.17 12/31/202382,700 shares $11,578.00 No ChangeN/A0 $0.14 11/30/202380,600 shares $11,084.11 +58.4%N/A0 $0.14 11/15/202350,900 shares $7,380.50 No ChangeN/A0 $0.15 10/15/2023228,000 shares $21,831.00 +113.5%N/A0.3 $0.10 9/30/2023106,800 shares $10,019.44 +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18,629.60 +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2,532.60 +102.4%N/A0 $0.04 7/15/202329,800 shares $1,132.40 No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1,701.70 +44.9%N/A0.1 $0.04 1/31/202330,500 shares $1,030.90 +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1,326.80 No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2,477.48 -2.8%N/A0 $0.04 8/15/202271,300 shares $3,208.50 No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04 2/28/2022212,900 shares $8,516.00 +3,030.9%N/A0.2 $0.04 2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04 1/31/202264,500 shares $2,547.75 No ChangeN/A0.1 $0.04 12/31/2021100 shares $3.31 No ChangeN/A0 $0.03 12/15/2021100 shares $3.70 -99.6%N/A0 $0.04 11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04 11/15/2021100 shares $3.82 -98.9%N/A0 $0.04 10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04 10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04 9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04 8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05 8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05 7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05 7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05 6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05 5/14/202121,600 shares $1,252.80 +151.2%N/A0 $0.06 4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05 3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06 3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06 2/26/202140,400 shares $2,585.60 +1,054.3%N/A0 $0.06 2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07 1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06 12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05 11/30/202027,400 shares $1,479.60 -68.4%N/A0 $0.05 11/15/202086,700 shares $6,675.90 No ChangeN/A0.1 $0.08 10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07 8/31/202073,800 shares $5,830.20 +939.4%N/A0 $0.08 8/14/20207,100 shares $477.83 -92.6%N/A0 $0.07 7/31/202096,500 shares $6,031.25 +222.7%N/A0.1 $0.06 7/15/202029,900 shares $2,299.31 +121.5%N/A0 $0.08 6/30/202013,500 shares $1,120.50 -59.0%N/A0 $0.08 6/15/202032,900 shares $2,961.00 No ChangeN/A0 $0.09 5/15/202022,200 shares $1,698.30 +27.6%N/A0 $0.08 4/30/202017,400 shares $1,392.00 No ChangeN/A0 $0.08 3/31/20209,600 shares $691.20 +3,100.0%N/A0 $0.07 3/13/2020300 shares $18.90 No ChangeN/A0 $0.06 2/28/2020300 shares $24.60 No ChangeN/A0 $0.08 2/14/2020300 shares $27.75 -99.7%N/A0 $0.09 1/31/202085,000 shares $8,670.00 +293.5%N/A0.1 $0.10 1/15/202021,600 shares $2,265.84 +7,100.0%N/A0 $0.10 12/31/2019300 shares $27.45 -98.7%N/A0 $0.09 ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,595,900 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest. What is a good short interest ratio for Elite Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 2.0. Learn More on Elite Pharmaceuticals's short interest ratio. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 1,595,900 shares, a drop of 0.3% from the previous total of 1,601,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Elite Pharmaceuticals: Rigel Pharmaceuticals, Inc. (3.23%), RAPT Therapeutics, Inc. (9.23%), Alimera Sciences, Inc. (0.23%), InterCure Ltd. (0.15%), Sagimet Biosciences Inc. (12.78%), Gossamer Bio, Inc. (5.68%), Incannex Healthcare Inc. (0.48%), Syros Pharmaceuticals, Inc. (7.79%), Context Therapeutics Inc. (0.05%), Greenwich LifeSciences, Inc. (3.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Rigel Pharmaceuticals Short Interest RAPT Therapeutics Short Interest Alimera Sciences Short Interest InterCure Short Interest Sagimet Biosciences Short Interest Gossamer Bio Short Interest Incannex Healthcare Short Interest Syros Pharmaceuticals Short Interest Context Therapeutics Short Interest Greenwich LifeSciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.